Myrcene,75% (stabilized with BHT)

Myrcene (β-Myrcene) is a type of aromatic compound that inhibits TNFα and NF-κB activity. Myrcene has anti-invasive action, inhibits cell cycle, and leads to cancer cell apoptosis. Myrcene has strong blood protection effect, anti-inflammation, and anti-inflammatory activity[1][2][3][4][5].

Product Specifications

CAS Number

[123-35-3]

Product Name Alternative

β-Myrcene

UNSPSC

12352211

Hazard Statement

H226, H315, H319, H351, H410

Target

NF-κB

Type

Natural Products

Related Pathways

NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/myrcene.html

Purity

75.0

Solubility

DMSO : 100 mg/mL (ultrasonic) |Ethanol : ≥ 100 mg/mL

Smiles

C=CC(CC/C=C(C)/C)=C

Molecular Formula

C10H16

Molecular Weight

136.23

Precautions

H226, H315, H319, H351, H410

References & Citations

[1]Eunson Hwang, et al. Myrcene, an Aromatic Volatile Compound, Ameliorates Human Skin Extrinsic Aging via Regulation of MMPs Production. Am J Chin Med. 2017;45 (5) :1113-1124.|[2]Jeong-Ho Lee, et al. Anti-invasive effect of β-myrcene, a component of the essential oil from Pinus koraiensis cones, in metastatic MDA-MB-231 human breast cancer cells. Journal of the Korean Society for Applied Biological Chemistry volume 58, pages563–569.|[3]Bai X, et al. Myrcene exhibits antitumor activity against lung cancer cells by inducing oxidative stress and apoptosis mechanisms[J]. Natural Product Communications, 2020, 15 (9) : 1934578X20961189.|[4]Islam AUS, et al. Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model. Molecules. 2020 Sep 30;25 (19) :4492.|[5]Kumar R, et al. Ameliorative effect of myrcene in mouse model of Alzheimer's disease. Eur J Pharmacol. 2021 Nov 15;911:174529.